Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: ChromaVision Medical Systems

This article was originally published in The Gray Sheet

Executive Summary

ChromaVision Medical Systems: Firm's Aug. 13 initial public offering totals approximately 7.4 mil. shares, including the sale of 640,000 overallotment shares sold by certain shareholders, the firm states. ChromaVision netted $29.2 mil. from its sale of 6,020,000 new shares at $5 each ("The Gray Sheet" Aug. 25, p. 13); shareholders sold a total of 1,020,000 additional shares, including the overallotments, and Safeguard Scientifics, which held 37.4% of the automated microscope maker prior to the offering, sold some shares but also gained 320,000 additional new shares under terms of the offering. Safeguard currently holds about 20% of the company. About 17.1 mil. shares are currently outstanding. Underwriters were Robert W. Baird & Co. and Adams, Harkness & Hill...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008745

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel